مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| تحلیل آماری بیزی ریسکهای رقیب× | مدل رگرسیون کوکس (Cox Proportional Hazards)× | |
|---|---|---|
| حوزه | اپیدمیولوژی | اپیدمیولوژی |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1980s–2000s (classical CR: 1970s; Bayesian extension: 1990s–2000s) | 1972 |
| پدیدآور≠ | Various; Bayesian formulation advanced by Gelfand, Dey, Larson, and Dinse among others | Sir David Roxbee Cox |
| نوع≠ | Bayesian survival/time-to-event model | Semi-parametric regression model |
| منبع بنیادین≠ | Larson, M. G., & Dinse, G. E. (1985). A mixture model for the regression analysis of competing risks data. Applied Statistics, 34(3), 201–211. DOI ↗ | Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202. DOI ↗ |
| نامهای دیگر | Bayesian cause-specific hazard model, Bayesian subdistribution hazard model, BCRA, Bayesian cumulative incidence analysis | Cox regression, Cox PH model, proportional hazards model, CPH |
| مرتبط≠ | 3 | 5 |
| خلاصه≠ | Bayesian competing risks analysis is a time-to-event method for settings where subjects can fail from more than one mutually exclusive cause — such as death from cancer versus death from cardiovascular disease — and prior knowledge or small-sample uncertainty makes a Bayesian framework advantageous. It extends classical competing risks models (cause-specific hazards and cumulative incidence functions) by placing probability distributions over unknown parameters and updating those distributions with observed data, yielding full posterior inference for each failure type. | The Cox proportional hazards model is a semi-parametric regression method that estimates the effect of one or more covariates on the hazard — the instantaneous rate of an event such as death, relapse, or failure — while making no assumption about the shape of the baseline hazard function. Introduced by David Cox in 1972, it is the dominant tool for multivariable survival analysis in clinical and epidemiological research. |
| ScholarGateمجموعهداده ↗ |
|
|